🤏 The Zephyr Valve is less than 10 mm in size, but offers huge clinical benefits! Do you want to learn more? Come meet our experts at the European Respiratory Society Congress 2024 in Vienna to discuss endobronchial valves as a standard of care treatment option for your severe COPD/emphysema patients! Patients treated with Zephyr Valves experienced benefits including improved lung function, exercise capacity and quality of life¹. Find out more and schedule an appointment right now👉 https://lnkd.in/erTvEYWN #Pulmonx #ERS2024 #ERSCongress 1.Criner, G et al. Am J Resp Crit Care Med. 2018;198(9):1151‒1164.
Pulmonx Corporation
Herstellung medizinischer Geräte
Redwood City, CA 16.194 Follower:innen
Improving Breathing and Quality of Life for Emphysema and Advanced COPD Patients
Info
Pulmonx has developed the Zephyr Endobronchial Valve, a minimally invasive treatment for COPD/emphysema. The one-time procedure is done by bronchoscopy and requires no cutting or incisions. During the procedure, on average 4 tiny valves are placed in the airways to block off the diseased parts of the lung which allows trapped air to escape until the lobe is reduced. Reducing hyperinflation allows the healthier parts of the lungs to expand and take in more air. This results in patients being able to breathe easier and have less shortness of breath.1 Complications of the Zephyr Endobronchial Valve treatment can include but are not limited to pneumothorax, worsening of COPD symptoms, hemoptysis, pneumonia, dyspnea and, in rare cases, death.1 1. Criner G et al AM J Resp Crit Care Med 2018, Published on 22-May-2018 as 10.1164/rccm.201803-0590OC Brief Statement: The Pulmonx Zephyr® Endobronchial Valves are implantable bronchial valves indicated for the bronchoscopic treatment of adult patients with hyperinflation associated with severe emphysema in regions of the lung that have little to no collateral ventilation. The Zephyr Valve is contraindicated for: Patients for whom bronchoscopic procedures are contraindicated; those with evidence of active pulmonary infection; known allergies to Nitinol (nickel-titanium) or its constituent metals (nickel or titanium); known allergies to silicone, or with large bullae encompassing greater than 30% of either lung; Patients who have not quit smoking. The Zephyr Valve should be used with caution and only after careful consideration in treating patients with: Prior lung transplant, LVRS, median sternotomy, or lobectomy; Congestive heart failure or recent myocardial infarction; FEV1 <15% of predicted value. Use is restricted to a trained physician. Prior to use, please reference the Zephyr Endobronchial Valve System Instructions for more information on indications, contraindications, warnings, all precautions, and adverse events.
- Website
-
http://www.Pulmonx.com
Externer Link zu Pulmonx Corporation
- Branche
- Herstellung medizinischer Geräte
- Größe
- 201–500 Beschäftigte
- Hauptsitz
- Redwood City, CA
- Art
- Privatunternehmen
- Spezialgebiete
- Medical Device, Interventional Pulmonology, Emphysema Treatment und Endobronchial Valve Therapy
Orte
-
Primär
Wegbeschreibung
700 Chesapeake Drive,
Redwood City, CA 94063, US
-
Wegbeschreibung
Rue de la Treille 4
Neuchâtel, 2000, CH
Beschäftigte von Pulmonx Corporation
Updates
-
Our upcoming webinar, "Pulmonary Rehabilitation: Use of a Standardized Tool to Identify Patients Eligible for Bronchoscopic Lung Volume Reduction (BLVR)," is just around the corner! Sara Buttery and Haley Hoy will provide valuable insights into implementing a pulmonary rehabilitation tool to identify patients who may benefit from BLVR with Zephyr Valves. 📅 Date: September 12 🕒 Time: 11:30 a.m. PT 🔗 Register now: https://lnkd.in/gdksm_Ye Join us to deepen your understanding and enhance your patient care strategies. We look forward to your participation. #Webinar #PulmonaryRehabilitation #Emphysema #LungHealth #MedicalEducation #BLVR
-
-
Are you a primary care provider with patients suffering from severe COPD/Emphysema? American Lung Association shares an interview with a pulmonologist talking about how endobronchial valves can help and which of your patients may qualify. https://bit.ly/3Mv3cBl #lungvalves #medtech
-
💡 Learn more about #newdata during ERS 2024 showing significant reduction in severe exacerbations in patient treated successfully with Zephyr Valves, a proven, minimally invasive treatment for severe COPD/emphysema. Come meet our team at the European Respiratory Society Congress 2024 in Vienna. Make the most of your time at the congress and schedule a one-on-one meeting with our experts 👉 https://lnkd.in/eVJMNRSR #Pulmonx #ERSCongress #ZephyrValves
Dieser Inhalt ist hier nicht verfügbar.
Mit der LinkedIn App können Sie auf diese und weitere Inhalte zugreifen.
-
Grateful for dedicated physicians like Dr. Patel who remind us why we do what we do. Stories like these inspire us to keep innovating for better patient outcomes every day. Results may vary.
Receiving a text like this makes your day and adds a reason to continue doing what you do. #Severe COPD #BLVR Faiz Bhora, M.D., FACS Paul C. Yodice MD FCCP FCCM Kostantinos Poulikidis, MD M. Jawad Latif Daniel Genovese, MBA John Perrotta, MBA, MHA, BS-RRT Blake Caplan Herminio Rivera MBA, BSN, RN Amie Thornton Pulmonx Corporation JFK Medical Center Todd Way Daniel Varga Robert C. Garrett Hackensack Meridian Health
-
-
Webinar: Pulmonary Rehabilitation: Use of a Standardized Tool to Identify Patients Eligible for Bronchoscopic Lung Volume Reduction (BLVR) Join us for an insightful session with Sara Buttery and Haley Hoy as they share their experience with implementing a pulmonary rehabilitation tool to identify patients who may benefit from BLVR with Zephyr Valves. Discussion will also include the foundation of pulmonary rehabilitation and its application in severe emphysema. 📅 Date: September 12 🕒 Time: 11:30 a.m. PT 🔗 Register now: https://lnkd.in/gdksm_Ye Don't miss this opportunity to learn more about advancing patient care in pulmonary health. #Webinar #PulmonaryRehabilitation #Emphysema #LungHealth #MedicalEducation #BLVR
-
-
Pulmonx Corporation hat dies direkt geteilt
I’d like to thank our talented summer interns for the fresh perspectives, eagerness to learn, and the dynamic energy they brought to our team this year. They gained valuable experience while contributing innovative ideas to help us in fighting every day, for every breath, so our patients don't have to. We're grateful for their hard work and enthusiasm! #InternshipExperience #Innovation #FutureLeaders Emily Agur Paul Tolley Stefan Bakiev Vinay Bhati Shruthi Suresh
-
-
We will be at the European Respiratory Society Congress 2024! Check out our booth A 1.08 to learn more about Zephyr Valves as a proven treatment for severe COPD/emphysema. Check out the presentations during #ERS2024, highlighting endobronchial valves as a possible treatment option and visit us for a hands-on experience with our solution, and to discuss patient selection and assessment tools. 🔎 Don’t miss out on the 5 years follow-up data from the LIBERATE Study. Find out more and schedule an appointment right now👉 https://lnkd.in/erTvEYWN #Pulmonx #ERS2024 #ERSCongress
Pulmonx at ERS 2024
-
📢 Live from AABIP 2024! 📢 We’re excited to be here at the AABIP 2024 Annual Conference! Visit us at booth #13 to see the Zephyr Endobronchial Valve in action – a proven treatment for patients struggling with severe #COPD/#emphysema. Don’t miss this chance to learn how our Zephyr Valve can help alleviate breathlessness and improve quality of life. Our team is here to answer your questions and demonstrate the impact of the Zephyr Valve. Come say hello and explore the future of pulmonary care! #AABIP2024 #PulmonaryHealth #MedTech #HealthcareInnovation #Bronchology #Pulmonx
-
-
More than 3 in 4 patients would select a treatment with the clinical benefits and risk profile of the Zephyr Valve over their current treatment. Read how the breakthrough technology may help your severe #COPD/#emphysema patients: https://bit.ly/3SXSAia #MedicalDevices #Pulmonology
-